risankizumab-rzaa intravenous infusion — Medica

Crohn’s disease

Initial criteria

age ≥ 18 years
Medication will be used as induction therapy
Patient meets ONE of the following: (i) tried or currently taking a systemic corticosteroid, or corticosteroid is contraindicated; OR (ii) tried one other conventional systemic therapy (e.g., azathioprine, 6-mercaptopurine, or methotrexate); OR (iii) has enterocutaneous (perianal or abdominal) or rectovaginal fistulas; OR (iv) had ileocolonic resection (to reduce recurrence)
An exception to the requirement for a trial of steroid or conventional systemic agent can be made if the patient has already tried at least one biologic other than the requested medication (biosimilar does not count; mesalamine does not count as systemic agent)
Prescribed by or in consultation with a gastroenterologist

3 months